Joyzyme Group Limited (HKG:8622)
0.3200
0.00 (0.00%)
Apr 24, 2026, 4:08 PM HKT
Joyzyme Group Market Cap
Joyzyme Group has a market cap or net worth of 164.95 million as of April 24, 2026. Its market cap has increased by 6.32% in one year.
Market Cap
164.95M
Enterprise Value
123.82M
Revenue
31.47M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.32
Market Cap Chart
Since December 13, 2018, Joyzyme Group's market cap has decreased from 188.00M to 164.95M, a decrease of -12.26%. That is a compound annual growth rate of -1.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 164.95M | -26.44% |
| Dec 31, 2025 | 224.23M | 198.69% |
| Dec 31, 2024 | 75.07M | 67.66% |
| Dec 29, 2023 | 44.78M | -41.60% |
| Dec 30, 2022 | 76.68M | -22.70% |
| Dec 31, 2021 | 99.20M | 131.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 13, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lee's Pharmaceutical Holdings | 677.16M |
| China NT Pharma Group Company | 616.85M |
| Wai Yuen Tong Medicine Holdings | 395.61M |
| Extrawell Pharmaceutical Holdings | 223.30M |
| Shenzhen Neptunus Interlong Bio-technique Company | 216.46M |
| Tianda Pharmaceuticals | 208.55M |
| Regent Pacific Group | 183.84M |
| Kontafarma China Holdings | 167.66M |